ACHE and Alzheimer disease: Clinical research has also shown that treatment with CSZ is effective in preventing recurrent stroke (Shi et al., 2014) and therapy with CSZ improves the cognitive impairments in patients with stable AD receiving acetylcholinesterase inhibitors (Tai et al., 2017).